Data analytics and automation platform Alteryx will be announcing earnings results tomorrow after market close. Here's what to expect.
Last quarter Alteryx reported revenues of $180.6 million, up 50.4% year on year, beating analyst revenue expectations by 12.2%. It was an incredible quarter for the company, with an impressive beat of analyst estimates and very optimistic guidance for the next quarter. The company added 101 customers to a total of 8,296.
Is Alteryx buy or sell heading into the earnings? Read our full analysis here, it's free.
This quarter analysts are expecting Alteryx's revenue to grow 55.7% year on year to $192.3 million, improving on the 4.79% year-over-year decline in revenue the company had recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.10 per share.
Majority of analysts covering the company have reconfirmed their estimates over the last thirty days, suggesting they are expecting the business to stay the course heading into the earnings. The company has a history of exceeding Wall St's expectations, beating revenue estimates every single time over the past two years on average by 7.13%.
With Alteryx being the first among its peers to report earnings this season, we don't have anywhere else to look at to get a hint at how this quarter will unravel for software stocks, but investors in the segment have had steady hands going into the earnings, with the stocks up on average 1.96% over the last month. Alteryx is down 12.3% during the same time, and is heading into the earnings with analyst price target of $74.74, compared to share price of $49.46.
One way to find opportunities in the market is to watch for generational shifts in the economy. Almost every company is slowly finding itself becoming a technology company and facing cybersecurity risks and as a result, the demand for cloud-native cybersecurity is skyrocketing. This company is leading a massive technological shift in the industry and with revenue growth of 70% year on year and best-in-class SaaS metrics it should definitely be on your radar.
The author has no position in any of the stocks mentioned.